Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih T, Yao JC (2017) Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 3:1335–1342

Article  PubMed  PubMed Central  Google Scholar 

Hallet J, Law CH, Cukier M, Saskin R, Liu N, Singh S (2015) Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer 121:589–597

Article  PubMed  Google Scholar 

Sonbol MB, Mazza GL, Mi L, Oliver T, Starr J, Gudmundsdottir H, Cleary SP, Hobday T, Halfdanarson TR (2022) Survival and incidence patterns of pancreatic neuroendocrine tumors over the last 2 decades: A SEER database analysis. Oncologist 27:573–578

Article  PubMed  PubMed Central  Google Scholar 

White BE, Rous B, Chandrakumaran K, Wong K, Bouvier C, Van Hemelrijck M, George G, Russell B, Srirajaskanthan R, Ramage JK (2022) Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study. Lancet Reg Health Eur 23:100510

Article  PubMed  PubMed Central  Google Scholar 

Thiis-Evensen E, Boyar Cetinkaya R (2023) Incidence and prevalence of neuroendocrine neoplasms in Norway 1993–2021. J Neuroendocrinol 35:e13264

Article  CAS  PubMed  Google Scholar 

Pathak S, Starr JS, Halfdanarson T, Sonbol MB (2023) Understanding the increasing incidence of neuroendocrine tumors. Expert Rev Endocrinol Metab 18:377–385

Article  CAS  PubMed  Google Scholar 

Bonazzi N, Fortunati E, Zanoni L, Argalia G, Calabro D, Tabacchi E, Allegri V, Campana D, Andrini E, Lamberti G, Di Franco M, Casadei R, Ricci C, Mosconi C, Fanti S, Ambrosini V (2024) Real-life use of [68Ga]Ga-DOTANOC PET/CT in confirmed and suspected NETs from a prospective 5-year electronic archive at an ENETS center of excellence: more than 2000 scans in more than 1500 patients. Cancers (Basel) 16

Franchellucci G, Andreozzi M, Carrara S, De Luca L, Auriemma F, Paduano D, Calabrese F, Facciorusso A, Poletti V, Zerbi A, Lania AG, Bertuzzi AF, Spaggiari P, Pedicini V, Rodari M, Fusaroli P, Lisotti A, Ofosu A, Repici A, Mangiavillano B (2023) Contrast enhanced EUS for predicting solid pancreatic neuroendocrine tumor grade and aggressiveness. Diagnostics (Basel) 13

Partelli S, Cirocchi R, Crippa S, Cardinali L, Fendrich V, Bartsch DK, Falconi M (2017) Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms. Br J Surg 104:34–41

Article  CAS  PubMed  Google Scholar 

Pavel M, Oberg K, Falconi M, Krenning EP, Sundin A, Perren A, Berruti A (2020) Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 31:844–860

Article  CAS  PubMed  Google Scholar 

Scott AT, Howe JR (2019) Evaluation and management of neuroendocrine tumors of the pancreas. Surg Clin North Am 99:793–814

Article  PubMed  PubMed Central  Google Scholar 

Kos-Kudla B, Castano JP, Denecke T, Grande E, Kjaer A, Koumarianou A, de Mestier L, Partelli S, Perren A, Stattner S, Valle JW, Fazio N (2023) European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours. J Neuroendocrinol 35:e13343

Article  CAS  PubMed  Google Scholar 

Hofland J, Falconi M, Christ E, Castano JP, Faggiano A, Lamarca A, Perren A, Petrucci S, Prasad V, Ruszniewski P, Thirlwell C, Vullierme MP, Welin S, Bartsch DK (2023) European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes. J Neuroendocrinol 35:e13318

Article  CAS  PubMed  Google Scholar 

Halfdanarson TR, Strosberg JR, Tang L, Bellizzi AM, Bergsland EK, O’Dorisio TM, Halperin DM, Fishbein L, Eads J, Hope TA, Singh S, Salem R, Metz DC, Naraev BG, Reidy-Lagunes DL, Howe JR, Pommier RF, Menda Y, Chan JA (2020) The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of pancreatic neuroendocrine tumors. Pancreas 49:863–881

Article  PubMed  Google Scholar 

Mizuide M, Ryozawa S, Fujita A, Ogawa T, Katsuda H, Suzuki M, Noguchi T, Tanisaka Y (2020) Complications of endoscopic ultrasound-guided fine needle aspiration: a narrative review. Diagnostics (Basel) 10

Tian G, Ye Z, Zhao Q, Jiang T (2020) Complication incidence of EUS-guided pancreas biopsy: A systematic review and meta-analysis of 11 thousand population from 78 cohort studies. Asian J Surg 43:1049–1055

Article  PubMed  Google Scholar 

Sakellis C, Jacene HA (2024) Neuroendocrine tumors: diagnostics. PET Clin 19:325–339

PubMed  Google Scholar 

Kandathil A, Subramaniam RM (2023) Gastroenteropancreatic neuroendocrine tumor diagnosis: DOTATATE PET/CT. PET Clin 18:189–200

Article  PubMed  Google Scholar 

Szidonya L, Park EA, Kwak JJ, Mallak N (2022) Molecular and anatomic imaging of neuroendocrine tumors. Surg Oncol Clin N Am 31:649–671

Article  PubMed  Google Scholar 

Frilling A, Sotiropoulos GC, Radtke A, Malago M, Bockisch A, Kuehl H, Li J, Broelsch CE (2010) The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors. Ann Surg 252:850–856

Article  PubMed  Google Scholar 

Koffas A, Giakoustidis A, Papaefthymiou A, Bangeas P, Giakoustidis D, Papadopoulos VN, Toumpanakis C (2023) Diagnostic work-up and advancement in the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. Front Surg 10:1064145

Article  PubMed  PubMed Central  Google Scholar 

Hope TA, Bergsland EK, Bozkurt MF, Graham M, Heaney AP, Herrmann K, Howe JR, Kulke MH, Kunz PL, Mailman J, May L, Metz DC, Millo C, O’Dorisio S, Reidy-Lagunes DL, Soulen MC, Strosberg JR (2018) Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors. J Nucl Med 59:66–74

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hope TA (2020) Updates to the appropriate-use criteria for somatostatin receptor PET. J Nucl Med 61:1764

Article  PubMed  Google Scholar 

Hope TA, Allen-Auerbach M, Bodei L, Calais J, Dahlbom M, Dunnwald LK, Graham MM, Jacene HA, Heath CL, Mittra ES, Wright CL, Fendler WP, Herrmann K, Taieb D, Kjaer A (2023) SNMMI procedure standard/EANM practice guideline for SSTR PET: imaging neuroendocrine tumors. J Nucl Med 64:204–210

Article  CAS  PubMed  Google Scholar 

Casey M, Brown A, Romero-Hernandez F, Wang JJ, Ganjouei AA, Tozzi F, Rashidian N, Kirkwood K, Corvera C, Nakakura E, Alseidi A, Adam M (2024) National practice patterns in the use of endoscopic ultrasound biopsy for resectable Pancreatic Neuroendocrine Tumors: Insights into the role of DOTATATE PET/CT in diagnosis. Am J Surg:115779

Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J, Cremonesi M, de Herder WW, Dromain C, Falconi M, Fani M, Fanti S, Hicks RJ, Kabasakal L, Kaltsas G, Lewington V, Minozzi S, Cinquini M, Oberg K, Oyen WJG, O’Toole D, Pavel M, Ruszniewski P, Scarpa A, Strosberg J, Sundin A, Taieb D, Virgolini I, Wild D, Herrmann K, Yao J (2021) Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. Eur J Cancer 146:56–73

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leyden S, Kolarova T, Bouvier C, Caplin M, Conroy S, Davies P, Dureja S, Falconi M, Ferolla P, Fisher G, Goldstein G, Hicks RJ, Lawrence B, Majima Y, Metz DC, O’Toole D, Ruszniewski P, Wiedenmann B, Hollander R, International Neuroendocrine Cancer A (2020) Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals. Int J Cancer 146:1316–1323

Article  Google Scholar 

Sundin A, Arnold R, Baudin E, Cwikla JB, Eriksson B, Fanti S, Fazio N, Giammarile F, Hicks RJ, Kjaer A, Krenning E, Kwekkeboom D, Lombard-Bohas C, O’Connor JM, O’Toole D, Rockall A, Wiedenmann B, Valle JW, Vullierme MP, Antibes Consensus Conference participants (2017) ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imaging. Neuroendocrinology 105:212–244

Article  CAS  PubMed  Google Scholar 

Shah MH, Goldner WS, Benson AB, Bergsland E, Blaszkowsky LS, Brock P, Chan J, Das S, Dickson PV, Fanta P, Giordano T, Halfdanarson TR, Halperin D, He J, Heaney A, Heslin MJ, Kandeel F, Kardan A, Khan SA, Kuvshinoff BW, Lieu C, Miller K, Pillarisetty VG, Reidy D, Salgado SA, Shaheen S, Soares HP, Soulen MC, Strosberg JR, Sussman CR, Trikalinos NA, Uboha NA, Vijayvergia N, Wong T, Lynn B, Hochstetler C (2021) Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 19:839–868

Article  CAS  PubMed  Google Scholar 

Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, Chan J, Kulke MH, Benson AB, Blaszkowsky LS, Eads J, Engstrom PF, Fanta P, Giordano T, He J, Heslin MJ, Kalemkerian GP, Kandeel F, Khan SA, Kidwai WZ, Kunz PL, Kuvshinoff BW, Lieu C, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Sussman CA, Trikalinos NA, Uboha NA, Whisenant J, Wong T, Yao JC, Burns JL, Ogba N, Zuccarino-Catania G (2018) NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018. J Natl Compr Canc Netw 16:693–702

Article  CAS  PubMed  Google Scholar 

Hasson F, Keeney S, McKenna H (2000) Research guidelines for the Delphi survey technique. J Adv Nurs 32:1008–1015

Article  CAS  PubMed  Google Scholar 

Junger S, Payne SA, Brine J, Radbruch L, Brearley SG (2017) Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: Recommendations based on a methodological systematic review. Palliat Med 31:684–706

Article  PubMed  Google Scholar 

Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, Caplin M, Kos-Kudla B, Kwekkeboom D, Rindi G, Kloppel G, Reed N, Kianmanesh R, Jense